Deals

Cadence Completes Acquisition of Evatronix IP Business

SAN JOSE, CA, Jun 13, 2013 (Marketwired via COMTEX) — Cadence Design Systems, Inc. , a leader in global electronic design innovation, today announced that it has completed the acquisition of the IP business of Poland-based Evatronix, SA SKA. Further strengthening Cadence’s portfolio of intellectual property cores, Evatronix delivers a silicon-proven... Read more of this article

---

Qatar Petroleum, Qapco sign tech license deal for Al Sejeel petchem project

DUBAI (ICIS)–Qatar Petroleum (QP) has signed a technology license contract with Qatar Petrochemical Co (Qapco) for the upcoming multibillion-dollar Al Sejeel Petrochemical Complex at Ras Laffan Industrial City, the company said late on Wednesday. Univation Technologies and Dow Chemical also share the contract with QP and Qapco for polyethylene (PP)... Read more of this article

---

Tianjin SinoBiotech & Beijing Bio-Fortune Announce a IP License for Neutropenia With Top 10 Pharma Co

BEIJING–(BUSINESS WIRE)–Prof. Zailin Yu, Yan Fu with Tianjin SinoBiotech Ltd. & Beijing Bio-Fortune Ltd. (the “Licensor”), privately held biotechnology and biopharmaceutical companies, announced today that they have entered into a US market patent license agreement with one of the global top 10 pharmaceutical companies (the “Licensee”)... Read more of this article

---

Cancer Research UK licenses ExpreS2ion’s protein production technology

ExpreS2ion Biotechnologies has licensed its Drosophila Schneider-2 cell-based technology platform, ExpreS2, for protein production to the Protein Purification Facility at Cancer Research UK’s London Research Institute. The Protein Purification Facility will leverage the cGMP compatible stable, non-lytic protein expression platform for expression... Read more of this article

---

Imagination signs license agreement with Toshiba for range of Imagination’s technologies

Imagination Technologies (LSE: IMG.L), a leading multimedia, processor, communications and cloud technologies company, reports that it has signed a license agreement with Toshiba Corporation (TOKYO: 6502) for a range of technologies from Imagination’s Ensigma connectivity and PowerVR graphics and video families. Toshiba will deploy the technologies... Read more of this article

---

Immersion Licenses Haptic Technology to Sharp Corporation

SAN JOSE, Calif. –Immersion Corporation (Nasdaq:IMMR), the leading developer and licensor of touch feedback technology, today announced that the recently released docomo AQUOS PHONE ZETA SH-06E manufactured by Sharp includes Immersion’s haptics technology. The smartphone includes Immersion’s TouchSense® and Integrator software and is Sharp’s... Read more of this article

---

WiLAN buys patent portfolio from Cypress Semiconductor

Ottawa-based patent licensing company Wi-LAN Inc. says it has acquired a portfolio of patents from California-based technology company Cypress Semiconductor Corp. Terms of the deal for the patents, which are related to phase locked loop technology used in a wide range of semiconductor products, were not disclosed. However, WiLAN said Tuesday that... Read more of this article

---

ZTE Signs World Wide Patent License Agreement Covering Dolby Audio Technologies

SAN FRANCISCO–(BUSINESS WIRE)– Dolby Laboratories, Inc. (NYSE: DLB) announced that ZTE Corporation (ZTE) has taken a worldwide patent license for Dolby’s portfolio covering High-Efficiency Advanced Audio Coding (HE AAC). “ZTE’s leadership in the mobile market depends on innovation and intellectual property,” said... Read more of this article

---

BioLineRx signs out-licensing agreement with CTTQ

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. (CTTQ), the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis... Read more of this article

---

AMAG Pharmaceuticals Obtains US Commercial Rights to MuGard A Prescription Oral Rinse

LEXINGTON, Mass., June 10, 2013 (GLOBE NEWSWIRE) – AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today that it has licensed the US commercial rights to MuGard™, a marketed product for the management of oral mucositis, from Access Pharmaceuticals, Inc.(OTCBB:ACCP). MuGard is an oral mucoadhesive that is designed to manage oral mucositis... Read more of this article

---

More Posts From Deals